Page: Our Vision
To be the leading intelligence and strategy partner, empowering pharma, biotech, academia, and investors to identify, evaluate, and act on high-value opportunities in life sciences.
Who We Are
Bioloupe is a next-generation intelligence and strategy platform built to accelerate smarter decision-making in life sciences. We combine structured, proprietary data with strategic expertise to help innovators move faster and more confidently—from early discovery to commercialization.
In life sciences, data is abundant but rarely decision-ready. It's fragmented, raw, and trapped in silos—making it difficult to extract insights when they matter most. At Bioloupe, we transform unstructured information into clear, connected intelligence—bridging the gap between data and action.
We launched with a focus on oncology and hematology, but our platform is built for scale. Additional therapeutic areas are already in development, with expansion planned throughout this year.
We serve decision-makers across the ecosystem:
Pharma and biotech shaping pipeline, portfolio, and commercial strategy
Academia translating research into real-world impact
Investors evaluating differentiated opportunities in a crowded landscape
What Makes Us Different
AI + Expert Curation
Our data isn’t scraped—it’s structured. We combine advanced AI with deep manual curation to deliver reliable, searchable, and decision-ready intelligence.
From Data to Strategy
Beyond insights, we offer strategic consulting from a seasoned team with decades of experience across development, launch, and commercialization.
Deep Therapeutic Focus—With Expansion Ahead
We started in oncology and hematology, where the need is acute and complexity is high. But we’re not stopping there—new therapeutic areas are on the way.
Meet the Founders
Laszlo Danko and Viji Padmanabhan founded Bioloupe in 2023 after years in global pharmaceutical leadership roles. Having experienced firsthand how fragmented data and slow strategy cycles can delay innovation, they created Bioloupe to help life science leaders make confident, data-driven decisions—faster.
Laszlo Danko
Laszlo Danko is an entrepreneur and seasoned pharmaceutical leader with over 25 years of international experience driving strategy and innovation in oncology, hematology, and specialty care. He holds an MSc in Molecular Biology and an MBA.
Viji Padmanabhan
Viji Padmanabhan is an entrepreneur and seasoned pharmaceutical executive with over 25 years of global leadership experience in business analytics, forecasting, and data-driven decision support. She holds an M.A. in Economics.
Looking to make data-driven decisions in biopharma?
Let’s explore how Bioloupe can empower your strategy.